Evidence map›Paper›PMID 32021345›Full record

ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2019

Circulating Tissue Factor-Positive Procoagulant Microparticles in Patients with Type 1 Diabetes.

Chenghui Zhang, Qing Ou, Yan Gu, Gaiping Cheng, Rong Du, Li Yuan, Ruth Lm Cordiner, Deying Kang, Jiaying Zhang, Qiaorong Huang and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Antiviral anticoagulation.Research and practice in thrombosis and haemostasis · 2020
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Chenghui Zhang *Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Qing Ou *Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Yan Gu *Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Gaiping ChengDepartment of Clinical Nutrition, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Rong DuDepartment of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Li YuanDepartment of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Ruth Lm CordinerDivision of Population Health and Genomics, Ninewells Hospital and School of Medicine, University of Dundee, Dundee DD1 9SY, Scotland, UK.
Deying KangChinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.ORCID 0000-0003-1488-7047
Jiaying ZhangDepartment of Ophthalmology, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Qiaorong HuangLaboratory of Stem Cell Biology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Chuan YuDepartment of Health-Related Social and Behavioral Science, West China School of Public Health, Sichuan University, Chengdu 610041, People's Republic of China.
Li KangDivision of Systems Medicine, Ninewells Hospital and School of Medicine, University of Dundee, Dundee DD1 9SY, Scotland, UK.
Xuan WangDivision of Population Health and Genomics, Ninewells Hospital and School of Medicine, University of Dundee, Dundee DD1 9SY, Scotland, UK.
Xin SunChinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Xianming MoLaboratory of Stem Cell Biology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Haoming TianDepartment of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.ORCID 0000-0002-1921-4733
Ewan R PearsonDivision of Population Health and Genomics, Ninewells Hospital and School of Medicine, University of Dundee, Dundee DD1 9SY, Scotland, UK.
Wentong MengLaboratory of Stem Cell Biology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Sheyu LiDepartment of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.ORCID 0000-0003-0060-0287

Funding

British Heart Foundation PG/18/56/33935Chief Scientist Office CGA/19/10Wellcome Trust
6 · The paper itself

Abstract

aimTo investigate the count of circulating tissue factor-positive (TF

methodsThis case-control study included patients with T1DM and age and sex-matched healthy volunteers. The counts of phosphatidylserine-positive (PS

resultsWe recruited 36 patients with T1DM and 36 matched healthy controls. Compared with healthy volunteers, PS

conclusionCirculating TF

Indexed as

diabetic retinopathymicroparticlestissue factortype 1 diabetes mellitus

Identifiers

PMID32021345
PMCPMC6978680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.